Citation: | NIU Kai-xuan, WU Shu-lu, LIU Cheng, DENG Xi-ming. Clinical value of serum amyloid A and interleukin-6 in the diagnosis and severity evaluation of sepsis[J]. Chinese Journal of General Practice, 2022, 20(9): 1484-1487. doi: 10.16766/j.cnki.issn.1674-4152.002629 |
[1] |
TAN M C, LU Y X, JIANG H, et al. The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis[J]. J Cell Biochem, 2019, 120(4): 5852-5859. doi: 10.1002/jcb.27870
|
[2] |
HUANG M, CAI S L, SU J Q. The pathogenesis of sepsis and potential therapeutic targets[J]. Int J Mol Sci, 2019, 20(21): 5376. doi: 10.3390/ijms20215376
|
[3] |
中国中西医结合学会检验医学专业委员会. 血清淀粉样蛋白A在感染性疾病中临床应用的专家共识[J]. 中华检验医学杂志, 2019, 42(3): 186-192.
Laboratory Medicine Committee of Chinese Association of Integrated Traditional Chinese and Western Medicine. Expert consensus on clinical application of serum amyloid A in infectious diseases[J]. Chinese Journal of Laboratory Medicine, 2019, 42(3): 186-192.
|
[4] |
HU P Y, CHEN Y L, PANG J M, et al. Association between IL-6 polymorphisms and sepsis[J]. Innate Immun, 2019, 25(8): 465-472. doi: 10.1177/1753425919872818
|
[5] |
孙晓琪, 刘贤英, 陈颖, 等. 血清降钙素原在脓毒症临床诊断中的应用研究[J]. 中华医院感染学杂志, 2019, 29(14): 2095-2098. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201914006.htm
SUN X Q, LIU X Y, CHEN Y, et al. Clinical value of serum procalcitonin in diagnosis of sepsis[J]. Chinese Journal of Nosocomiology, 2019, 29(14): 2095-2098. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201914006.htm
|
[6] |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi: 10.1001/jama.2016.0287
|
[7] |
RUDD K E, JOHNSON S C, AGESA K M, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219): 200-211. doi: 10.1016/S0140-6736(19)32989-7
|
[8] |
QU J Y, FENG P, LUO Y, et al. Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases[J]. Medicine (Baltimore), 2016, 95(30): e4270. DOI: 10.1097/MD.0000000000004270.
|
[9] |
TRENCHEVSKA O, YASSINE H N, BORGES C R, et al. Development of quantitative mass spectrometric immunoassay for serum amyloid A[J]. Biomarkers, 2016, 21(8): 743-751. doi: 10.1080/1354750X.2016.1201533
|
[10] |
曹琳, 宋晓文, 任金来, 等. 血清淀粉样蛋白A的研究进展[J]. 安徽医药, 2019, 23(2): 221-224. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYY201902004.htm
CAO L, SONG X W, REN J L, et al. Advances in research into serum amyloid A[J]. Anhui Medical and Pharmaceutical Journal, 2019, 23(2): 221-224. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYY201902004.htm
|
[11] |
DE BUCK M, GOUWY M, WANG J M, et al. Structure and expression of different serum amyloid A (SAA) vari-ants and their concentration-dependent functions during host insults[J]. Curr Med Chem, 2016, 23(17): 1725-1755. doi: 10.2174/0929867323666160418114600
|
[12] |
ROSE-JOHN S. Interleukin-6 family cytokines[J]. Cold Spring Harb Perspect Biol, 2018, 10(2): a028415. DOI: 10.1101/cshperspect.a028415.
|
[13] |
SONG J, PARK D W, MOON S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: A prospective controlled study according to the Sepsis-3 definitions[J]. BMC Infect Dis, 2019, 19(1): 968. doi: 10.1186/s12879-019-4618-7
|
[14] |
HOU T Y, HUANG D H, ZENG R, et al. Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: A systematic review and meta-analysis[J]. Int J Clin Exp Med, 2015, 8(9): 15238-15245.
|
[15] |
宫榭阳, 徐鹏, 葛长宇, 等. IL-6在卵巢癌中的研究进展[J]. 中华全科医学, 2019, 17(3): 455-458. doi: 10.16766/j.cnki.issn.1674-4152.000707
GONG X Y, XU P, GE C Y, et al. Research progress on IL-6 in ovarian cancer[J]. Chinese Journal of General Practice, 2019, 17(3): 455-458. doi: 10.16766/j.cnki.issn.1674-4152.000707
|
[16] |
PIERRAKOS C, VINCENT J L. Sepsis biomarkers: A review[J]. Crit Care, 2010, 14(1): R15. DOI: 10.1186/cc8872.
|
[17] |
PIERRAKOS C, VELISSARIS D, BISDORFF M, et al. Biomarkers of sepsis: Time for a reappraisal[J]. Crit Care, 2020, 24(1): 287. doi: 10.1186/s13054-020-02993-5
|